BioBrit
Overview
BioBrit is a life sciences consulting and investment firm located in La Jolla, California, focusing on transformative strategies for businesses in the biotech and pharmaceutical sectors. The firm is distinguished by its expertise in bringing novel medicines to market and maximizing shareholder value.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| RNAV8 Bio | Mar 2025 | Seed | Co-investor |
| Abintus Bio | Aug 2022 | Series B | Co-investor |
| Creyon Bio | Mar 2022 | Seed | Co-investor |
| Seraphina Therapeutics, Inc. | Oct 2021 | Series A Extension | Co-investor |
| Amplo Biotechnology | Oct 2021 | Seed | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is BioBrit based?
BioBrit is headquartered in La Jolla, California, United States.
When was BioBrit founded?
BioBrit was founded in 2012.
How many portfolio companies does BioBrit have?
BioBrit has 10 portfolio companies in Caplight's dataset.
What are some companies in BioBrit's portfolio?
Recent investments visible on Caplight include RNAV8 Bio, Abintus Bio, Creyon Bio, Seraphina Therapeutics, Inc., Amplo Biotechnology.
What was BioBrit's most recent investment?
BioBrit's most recent investment on Caplight was in RNAV8 Bio in 2025.
What sectors does BioBrit focus on?
BioBrit focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Energy & Sustainability, Real Estate & PropTech, Consumer & Commerce, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure.
What company stages does BioBrit focus on?
BioBrit typically invests at the Early stage.
What is BioBrit's AUM?
BioBrit's assets under management are estimated between $0.0 and $50.0M.